Patents by Inventor Catherine G. Ambrose

Catherine G. Ambrose has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170073736
    Abstract: Sequence specific DNA amplification and analysis techniques are provided. In some aspects, methods of the embodiments comprise amplifying sequence from two regions of a target sequence in the presence of a blocking oligonucleotide (e.g., such as a phosphorothioate-containing oligonucleotide) that hybridizes to the target sequence between the two regions. In some specific embodiments, a method is provided for detecting bacteria (such as detecting gram-positive or gram-negative bacteria) in a biological sample using polymerase chain reaction (PCR).
    Type: Application
    Filed: July 29, 2016
    Publication date: March 16, 2017
    Inventors: Douglas Bryan LITWIN, Heidi B. KAPLAN, Catherine G. AMBROSE, Anahita DUA, John B. HOLCOMB, Charles E. WADE, Fernando ANDRADE, John Darrell LIU
  • Patent number: 8986737
    Abstract: A method of treating or preventing infection at a surgical site comprising a bony defect and an implanted metal device is disclosed. Biodegradable microspheres are placed at the site and are capable of near-linear controlled release of an antibiotic agent for a predetermined period of time. The microspheres are configured to be large enough to avoid being phagocytosed and removed from the body, and small enough in diameter to not physically inhibit bone growth at said bony defect site. The microspheres are formed of polylactic-co-glycolic acid (PLGA), with or without polyethylene glycol (PEG), and sufficient antibiotic agent to produce bactericidal levels in body tissues. The microspheres exhibit near-linear delivery of the antibiotic agent for at least 4 weeks at levels exceeding the minimum inhibitory concentration (MIC) for organisms commonly found to be the cause of infections, and facilitate bone ingrowth or regrowth at the site.
    Type: Grant
    Filed: December 10, 2008
    Date of Patent: March 24, 2015
    Assignees: Wm. Marsh Rice University, Board of Regents of the Univeristy of Texas System
    Inventors: Catherine G. Ambrose, Terry A. Clyburn, Antonio G. Mikos
  • Patent number: 8261949
    Abstract: An adjustable-volume liquid dispenser is disclosed. In one embodiment, an adjustable-volume liquid dispenser includes a spout and a plunger secured to the spout. The dispenser further includes a plunger lock moveable lengthwise along the plunger. The plunger lock is securable to the plunger at a plurality of positions on the plunger to adjust a volume of liquid to be dispensed. The dispenser also includes a spring in contact with the plunger. In addition, the dispenser includes a chamber comprising an interior for containing liquid. The plunger is slidably arranged with the chamber. A portion of the plunger is disposed within the chamber. Moreover, the dispenser includes a chamber cap secured to the chamber, and a valve disposed within the chamber. The dispenser also includes a shaft secured to the chamber.
    Type: Grant
    Filed: February 8, 2008
    Date of Patent: September 11, 2012
    Inventors: Zillah Maria Oden, Gordon E. Schutze, Kimberly A. Bennett, Brian D. Schwab, Charles A. Ginnings, Megan E. Jeans, Catherine G. Ambrose
  • Publication number: 20090200341
    Abstract: An adjustable-volume liquid dispenser is disclosed. In one embodiment, an adjustable-volume liquid dispenser includes a spout and a plunger secured to the spout. The dispenser further includes a plunger lock moveable lengthwise along the plunger. The plunger lock is securable to the plunger at a plurality of positions on the plunger to adjust a volume of liquid to be dispensed. The dispenser also includes a spring in contact with the plunger. In addition, the dispenser includes a chamber comprising an interior for containing liquid. The plunger is slidably arranged with the chamber. A portion of the plunger is disposed within the chamber. Moreover, the dispenser includes a chamber cap secured to the chamber, and a valve disposed within the chamber. The dispenser also includes a shaft secured to the chamber.
    Type: Application
    Filed: February 8, 2008
    Publication date: August 13, 2009
    Applicants: William Marsh Rice University, Baylor College of Medicine
    Inventors: Zillah Maria Oden, Gordon E. Schutze, Kimberly A. Bennett, Brian D. Schwab, Charles A. Ginnings, Megan E. Jeans, Catherine G. Ambrose
  • Publication number: 20090148497
    Abstract: A method of treating or preventing infection at a surgical site comprising a bony defect and an implanted metal device is disclosed. Biodegradable microspheres are placed at the site and are capable of near-linear controlled release of an antibiotic agent for a predetermined period of time. The microspheres are configured to be large enough to avoid being phagocytosed and removed from the body, and small enough in diameter to not physically inhibit bone growth at said bony defect site. The microspheres are formed of polylactic-co-glycolic acid (PLGA), with or without polyethylene glycol (PEG), and sufficient antibiotic agent to produce bactericidal levels in body tissues. The microspheres exhibit near-linear delivery of the antibiotic agent for at least 4 weeks at levels exceeding the minimum inhibitory concentration (MIC) for organisms commonly found to be the cause of infections, and facilitate bone ingrowth or regrowth at the site.
    Type: Application
    Filed: December 10, 2008
    Publication date: June 11, 2009
    Inventors: Catherine G. Ambrose, Terry A. Clyburn, Antonio G. Mikos
  • Publication number: 20040131681
    Abstract: Biodegradable microspheres implanted, injected, or otherwise placed totally or partially within the body are capable of near-linear controlled release of an antibiotic for a predetermined period of time for the treatment and prevention of infections involving the body. The microspheres are formed of polylactic-co-glycolic acid (PLGA) and an effective amount of antibiotic sufficient to produce bactericidal levels in body tissues, and may or may not include polyethylene glycol (PEG). The microspheres exhibit near-linear delivery of the antibiotic for at least 4 weeks at levels exceeding the minimum inhibitory concentration (MIC) for organisms commonly found to be the cause of infections.
    Type: Application
    Filed: September 5, 2003
    Publication date: July 8, 2004
    Inventors: Catherine G. Ambrose, Terry A. Clyburn, Antonios G. Mikos